Novoron Bioscience Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $707K
Latest Deal Amount
  • Investors
  • 5

Novoron Bioscience General Information

Description

Operator of a private biotechnology company developing novel therapeutic approaches intended to address disorders of the central nervous system (CNS). The company has made proprietary scientific discoveries in treatment of various pathologies of the CNS and is advancing a pipeline of biologic therapeutics for multiple sclerosis and spinal cord injury.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 7770 Regents Road
  • Suite 113319
  • San Diego, CA 92122
  • United States
+1 (858) 000-0000

Novoron Bioscience Timeline

2017201820192020
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novoron Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Grant 01-Sep-2019 $707K 0000 Completed Pre-Clinical Trials
9. Grant 01-Apr-2019 00.000 0000 Completed Pre-Clinical Trials
8. Grant 01-Apr-2018 00000 0000 Completed Pre-Clinical Trials
7. Early Stage VC 02-Mar-2018 0000 0000 Completed Pre-Clinical Trials
6. Equity Crowdfunding Completed Pre-Clinical Trials
5. Accelerator/Incubator 13-Sep-2016 Completed Pre-Clinical Trials
4. Grant 01-Sep-2015 00000 Completed Pre-Clinical Trials
3. Accelerator/Incubator 22-Sep-2014 Completed Pre-Clinical Trials
2. Grant 01-Sep-2014 $25K Completed Pre-Clinical Trials
1. Grant 01-Aug-2014 $595K Completed Pre-Clinical Trials
To view Novoron Bioscience’s complete valuation and funding history, request access »

Novoron Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a private biotechnology company developing novel therapeutic approaches intended to address disorders of the
Biotechnology
San Diego, CA
0000
0000000000 0000

00000000

quat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla p
0000000000000
Cambridge, MA
0000000000

000000

m veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis au
0000 000000000
Cambridge, MA
0000 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Novoron Bioscience Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioAxone BioSciences Accelerator/Incubator Backed Cambridge, MA 0000000000
000000 Formerly VC-backed Cambridge, MA 0000 000.00 00000000000 000.00
To view Novoron Bioscience’s complete competitors history, request access »

Novoron Bioscience Executive Team (4)

Name Title Board Seat Contact Info
Travis Stiles Ph.D Co-Founder, Chief Executive Officer & President
Shawn Gahr Chief Financial Officer & Co-Founder
A. Taylor Bright Ph.D Chief Operating Officer & Co-Founder
To view Novoron Bioscience’s complete executive team members history, request access »

Novoron Bioscience Board Members (6)

Name Representing Role Since
Alban Gaultier Novoron Bioscience Board Member 000 0000
Jae Lee Novoron Bioscience Board Member 000 0000
Jeffrey Goldberg Novoron Bioscience Board Member 000 0000
Miguel de los Rios Ph.D Self Board Member 000 0000
Revere Kinkel Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Novoron Bioscience Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
Backstage Capital Venture Capital Minority 000 0000 000000 0
RESI on MaRS Innovation Other 000 0000 000000 0
JLABS Accelerator/Incubator Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
To view Novoron Bioscience’s complete investors history, request access »